Supplement Label Index
Advertisement

Houston Enzymes

Houston Enzymes has 15 on-market SKUs in the DSLD, first entered 2014-05-23. 80.0% of its products declare at least one proprietary blend, and 57.1% of all its all-time SKUs are now off-market.

15
on-market SKUs
80.0%
with a blend
0.0%
gummies
57.1%
off-market churn

Report card

  • Median dose adequacy (elemental dose ÷ studied low dose, pooled across compounds): —
  • % with a third-party certification statement (USP/NSF/Informed Sport/GMP, as asserted on label): 0.0%
  • Average excipient count per product: 3.9
  • First entry: 2014-05-23 · Latest entry: 2025-02-23

Products (35)

ProductFormStatus
AFP-Peptizyde with DPP IV Activity Capsule off-market
Lypazyme Capsule off-market
Lypazyme Capsule off-market
No-Fenol Capsule off-market
No-Fenol Capsule off-market
TriEnza Capsule off-market
TriEnza Capsule off-market
TriEnza Capsule off-market
TriEnza Capsule off-market
TriEnza Chewable Tablet or Pill off-market
TriEnza Chewable with DPP IV Activity Tablet or Pill off-market
TriEnza Powder Powder off-market
TriEnza Powder Powder off-market
TriEnza Powder with DPP IV Activity Powder off-market
TriEnza with DPP IV Activity Capsule off-market
TriEnza with DPP IV Activity Capsule off-market
ZyCarb Capsule off-market
Zyme Prime Capsule off-market
Zyme Prime Capsule off-market
Zyme Prime Capsule off-market
AFP-Peptizyde with DPP IV Activity Capsule on-market
AFP-Peptizyde with DPP IV Activity Capsule on-market
Biomuve Capsule on-market
Biomuve Capsule on-market
Lypazyme Capsule on-market
No-Fenol Capsule on-market
No-Fenol Chewable Tablet or Pill on-market
TriEnza Capsule on-market
TriEnza Capsule on-market
TriEnza Chewable Tablet or Pill on-market
TriEnza Powder Powder on-market
ZyCarb Capsule on-market
ZyCarb Capsule on-market
Zyme Prime Capsule on-market
Zyme Prime Chewable Pomegranate Raspberry Tablet or Pill on-market
Advertisement